Pages

Tuesday, May 20, 2008

Treatment of Recurrent Depression (Review of Psychiatry)



Product Description

Based on powerful epidemiological data such as numbers afflicted, mortality rates from suicide, personal and familial consequences, and skyrocketing fiscal costs, major depressive disorder (MDD) has the sad and ignominious distinction of being a leader among disabling disorders worldwide. With lifetime prevalence risks of 13% for men and 21% for women, the magnitude of this crisis cannot be understated. This hard-hitting volume focuses on recurrences perhaps most important among the many factors (others include extreme underdiagnosis and undertreatment, genetic vulnerability, frequent recurrences, severe stigma and poor adherence with maintenance treatment, and brain tissue degenerative changes associated with recurrences and chronic depression) that contribute to MDD's high morbidity.
Product Details

* Amazon Sales Rank: #1694683 in Books
* Published on: 2001-05
* Number of items: 1
* Binding: Paperback
* 189 pages

Editorial Reviews

Doody Health Science Review, September 2001
"This concise and clear presentation provides easy to understand statistical information about prevalence and types of treatment of recurrent depression."

Book Info
Univ. of Michigan, Ann Arbor. Offers clinicians treating depression and clinical neuroscientists information on the successful treatment of recurrent depression. Based on epidemiological data such as numbers afflicted, suicide mortality rates, and personal and familial consequences. Softcover. DNLM: Depressive Disorder--therapy.

About the Author
John F. Greden, M.D., is Rachel Upjohn Professor of Psychiatry and Clinical Neurosciences, Chair of the Department of Psychiatry, Senior Research Scientist at the Mental Health Research Institute, and Director of The University of Michigan Depression Center at The University of Michigan in Ann Arbor, Michigan.
Customer Reviews

Helpful to laymen too.5
Although written basically for psychiatrists and other clinicians, "The Treatment of Recurrent Depression," edited by John F. Greden, MD, Chairman of the Department of Psychiatry at the University of Michigan, is also beneficial to laymen interested in understanding depression and the various treatments available today.
The book actually consists of a series of chapters written by a variety of experts in the field, and includes such topics as: Advances in Brain Imaging; New and Integrated Treatments of Psychiatric Disorders; Recurrent Depression in Women; Pharmacotherapy and Psychotherapy Combinations; Prevention of Recurrences in Patients with Bi-Polar Disorder; and New Treatment Strategies.
Perhaps most interesting to the layman is Dr. Greden's introduction and his own included essay, "The Clinical Prevention of Recurrent Depression." In these he stresses the tremendous impact that recurrent depression has on our population. He issues the equivalent of a "call to arms," urging the need for a new paradigm for early detection, treatment and possible prevention.
As he says, "For success in stopping depression, we first must have success in improving detection." He stresses the need for early intervention and the development of tests to identify patients at risk for recurrences. He urges therapists to think long term, with maintenance treatments that are illness-focused, not episode focused. Most of all he urges the need for emphasizing adherence.
Patients, as well as family members and friends of patients, will benefit from this book. After reading it, they should realize there is a need to seek treatment for recurrent depression, to practice extended maintenance, and to approach recurrent depression as an on-going illness, just as one faces diabetes and heart disease.